UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 6‑K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
Dated February 18, 2020
 
Commission File Number: 001-38405
 
BIOCERES CROP SOLUTIONS CORP.
(Translation of registrant’s name into English)
 

 
Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F [ X ]       Form 40-F [  ]
 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
 

1

EXHIBIT INDEX

 
EXHIBIT
NO.
DESCRIPTION

 
2

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Bioceres Crop Solutions Corp. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

 
   
Bioceres Crop Solutions Corp.
   
(Registrant)
     
Date: February 18, 2020
By :
/s/ Federico Trucco
   
Name: Federico Trucco
Title: Chief Executive Officer

 
3
Exhibit 99.1
 
 
Bioceres Crop Solutions Corp. announces its subsidiary Rizobacter issued Corporate Bonds for a total of US$7.6 million
 
Rosario, Argentina / February 18, 2020 — Bioceres Crop Solutions Corp. (NYSE American: BIOX) (the “Company” or “Bioceres”) announced that Rizobacter Argentina S.A., Bioceres’ subsidiary (the “Issuer”), on February 14, 2020, completed the offering of US$7.6 million under Series II of its corporate bonds due 2021 (“Corporate Bonds”).
 
The Company intends to use the proceeds to improve its debt profile as well as for general corporate purposes, including working capital to further support international growth.
 
The Corporate Bonds were offered and sold only outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act of 1933, as amended (the “Securities Act”). The Corporate Bonds will not be registered under the Securities Act and may not be offered or sold in the United States without registration under the Securities Act or pursuant to an applicable exemption from such registration.
 
This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful.
 
About Bioceres Crop Solutions Corp.
 
Bioceres Crop Solutions Corp. (NYSE American: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4® program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit https://investors.biocerescrops.com

Forward Looking Statements

This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial information. Such forward-looking statements are based on management's reasonable current assumptions, expectations, plans and forecasts regarding the Company's and the Issuer's current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company or the Issuer to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management's expectations. Therefore, you should not rely on any of these forward-looking statements. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and Bioceres does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.

Contact:
Investor Relations
investor@biocerescrops.com
https://biocerescrops.com/investor-contact/